Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

STOKE THERAPEUTICS, INC. (STOK)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 1
  • 1 comments

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Market reaction Comment Full text

RIGEL PHARMACEUTICALS INC (RIGL)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 2
  • 1 comments

Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)

Market reaction Comment Full text

CEL SCI CORP (CVM)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 2
  • 1 comments

CEL-SCI Announces Closing of Offering

Market reaction Comment Full text

SHOPIFY INC. (SHOP)

  • Business News
  • June 16, 2026, 20:00 UTC
  • 5
  • 1 comments

Shopify Announces Results of its 2026 Annual Meeting of Shareholders

Market reaction Comment Full text

ROBERT HALF INC. (RHI)

  • Business News
  • June 16, 2026, 20:00 UTC
  • 3
  • 1 comments

Robert Half honored as one of the Best Places to Work in the Bay Area

Market reaction Comment Full text

LATTICE SEMICONDUCTOR CORP (LSCC)

  • Business News
  • June 16, 2026, 20:00 UTC
  • 1
  • 1 comments

Lattice to Showcase Industry-Leading FPGA Innovations at FPGA Conference Europe 2026

Market reaction Comment Full text

THOR INDUSTRIES INC (THO)

  • Business News
  • June 16, 2026, 19:30 UTC
  • 5
  • 1 comments

THOR INDUSTRIES ANNOUNCES REGULAR QUARTERLY DIVIDEND

Market reaction Comment Full text

TRACK GROUP, INC. (TRCK)

  • Business News
  • June 16, 2026, 19:25 UTC
  • 4
  • 1 comments

Track Group to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Market reaction Comment Full text

MICROSOFT CORP (MSFT)

  • Business News
  • June 16, 2026, 19:20 UTC
  • 3
  • 1 comments

Investor Notice: Robbins LLP Informs Investors of the Microsoft Corporation Class Action Lawsuit

Market reaction Comment Full text

GENMAB A/S (GMAB)

  • Business News
  • June 16, 2026, 19:12 UTC
  • 2
  • 1 comments

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Market reaction Comment Full text
  • Previous
  • 450
  • 451
  • 452
  • 453
  • 454
  • Next

Search

News categories

  • Technical Exchange News(13354)
  • Event(6229)
  • SEC News(342088)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189408)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin